ACADIA Pharmaceuticals Inc. earnings per share and revenue

ACAD earnings per share for the last quarter are 0.20 USD whereas the estimation was 0.14 USD which accounts for 44.84% surprise. Company revenue for the same period amounts to 250.40 M USD despite the estimated figure of 248.83 M USD. Estimated earnings per share for the next quarter are 0.22 USD, and revenue is expected to reach 271.64 M USD. Also watch annual changes over time to get a bigger picture of ACAD earnings per share and revenue dynamics.